Thomas G. Egwang

1.7k total citations
51 papers, 856 citations indexed

About

Thomas G. Egwang is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Thomas G. Egwang has authored 51 papers receiving a total of 856 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Public Health, Environmental and Occupational Health, 13 papers in Infectious Diseases and 11 papers in Molecular Biology. Recurrent topics in Thomas G. Egwang's work include Malaria Research and Control (27 papers), Mosquito-borne diseases and control (19 papers) and Parasitic Diseases Research and Treatment (11 papers). Thomas G. Egwang is often cited by papers focused on Malaria Research and Control (27 papers), Mosquito-borne diseases and control (19 papers) and Parasitic Diseases Research and Treatment (11 papers). Thomas G. Egwang collaborates with scholars based in Japan, Uganda and Gabon. Thomas G. Egwang's co-authors include Nirianne Palacpac, Toshihiro Horii, Elizabeth Balyejusa Kizito, Martín Fregene, Anna Westerbergh, Bernard N. Kanoi, M Pinder, Alain Dupont, Takafumi Tsuboi and Eizo Takashima and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and PLoS ONE.

In The Last Decade

Thomas G. Egwang

50 papers receiving 831 citations

Peers

Thomas G. Egwang
Nutan Nanda India
Luiz Hildebrando Pereira da Silva Brazil
Axel Martinelli United Kingdom
Ousmane Koita Mali
Nafissatou Diagne Senegal
Kailash P. Patra United States
Cielo Pasay Australia
Gustavo Fontecha Honduras
Albino Bobogare Australia
Hema Joshi India
Nutan Nanda India
Thomas G. Egwang
Citations per year, relative to Thomas G. Egwang Thomas G. Egwang (= 1×) peers Nutan Nanda

Countries citing papers authored by Thomas G. Egwang

Since Specialization
Citations

This map shows the geographic impact of Thomas G. Egwang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas G. Egwang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas G. Egwang more than expected).

Fields of papers citing papers by Thomas G. Egwang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas G. Egwang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas G. Egwang. The network helps show where Thomas G. Egwang may publish in the future.

Co-authorship network of co-authors of Thomas G. Egwang

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas G. Egwang. A scholar is included among the top collaborators of Thomas G. Egwang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas G. Egwang. Thomas G. Egwang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mu, Yi, Moses Adriko, Malcolm K. Jones, et al.. (2024). COVID-19 vaccination survey and anti-SARS-CoV-2 IgG responses in a human cohort from Schistosoma mansoni-endemic villages in Mayuge District, Uganda: a cross-sectional study. Frontiers in Public Health. 12. 1437063–1437063. 1 indexed citations
2.
McManus, Donald P., Haran Sivakumaran, Thomas G. Egwang, et al.. (2023). Development of CRISPR/Cas13a-based assays for the diagnosis of Schistosomiasis. EBioMedicine. 94. 104730–104730. 29 indexed citations
3.
Hergott, Dianna, Annette M. Seilie, Ming Chang, et al.. (2022). Rethinking detection of pre-existing and intervening Plasmodium infections in malaria clinical trials. Frontiers in Immunology. 13. 1003452–1003452. 5 indexed citations
4.
Takashima, Eizo, Bernard N. Kanoi, Hikaru Nagaoka, et al.. (2022). Meta-Analysis of Human Antibodies Against Plasmodium falciparum Variable Surface and Merozoite Stage Antigens. Frontiers in Immunology. 13. 887219–887219. 3 indexed citations
5.
Nagaoka, Hikaru, Bernard N. Kanoi, Masayuki Morita, et al.. (2020). Characterization of a Plasmodium falciparum PHISTc protein, PF3D7_0801000, in blood- stage malaria parasites. Parasitology International. 80. 102240–102240. 2 indexed citations
6.
Kanoi, Bernard N., Hikaru Nagaoka, Michael White, et al.. (2020). Global Repertoire of Human Antibodies Against Plasmodium falciparum RIFINs, SURFINs, and STEVORs in a Malaria Exposed Population. Frontiers in Immunology. 11. 893–893. 18 indexed citations
7.
Nagaoka, Hikaru, Bernard N. Kanoi, Masayuki Morita, et al.. (2019). The N-Terminal Region of Plasmodium falciparum MSP10 Is a Target of Protective Antibodies in Malaria and Is Important for PfGAMA/PfMSP10 Interaction. Frontiers in Immunology. 10. 2669–2669. 9 indexed citations
8.
9.
Balikagala, Betty, Toshihiro Mita, Mie Ikeda, et al.. (2017). Absence of in vivo selection for K13 mutations after artemether–lumefantrine treatment in Uganda. Malaria Journal. 16(1). 23–23. 19 indexed citations
10.
Ntege, Edward Hosea, Nobuko Arisue, Daisuke Ito, et al.. (2016). Identification of Plasmodium falciparum reticulocyte binding protein homologue 5-interacting protein, PfRipr, as a highly conserved blood-stage malaria vaccine candidate. Vaccine. 34(46). 5612–5622. 22 indexed citations
11.
Tougan, Takahiro, Kazuya Ito, Nirianne Palacpac, Thomas G. Egwang, & Toshihiro Horii. (2016). Immunogenicity and protection from malaria infection in BK-SE36 vaccinated volunteers in Uganda is not influenced by HLA-DRB1 alleles. Parasitology International. 65(5). 455–458. 2 indexed citations
12.
Yagi, Masanori, Nirianne Palacpac, Kazuya Ito, et al.. (2016). Antibody titres and boosting after natural malaria infection in BK-SE36 vaccine responders during a follow-up study in Uganda. Scientific Reports. 6(1). 34363–34363. 12 indexed citations
13.
Yagi, Masanori, Takahiro Tougan, Nirianne Palacpac, et al.. (2014). Protective Epitopes of the Plasmodium falciparum SERA5 Malaria Vaccine Reside in Intrinsically Unstructured N-Terminal Repetitive Sequences. PLoS ONE. 9(6). e98460–e98460. 33 indexed citations
14.
Ribacke, Ulf, Kirsten Moll, Letusa Albrecht, et al.. (2013). Improved In Vitro Culture of Plasmodium falciparum Permits Establishment of Clinical Isolates with Preserved Multiplication, Invasion and Rosetting Phenotypes. PLoS ONE. 8(7). e69781–e69781. 35 indexed citations
15.
16.
Kizito, Elizabeth Balyejusa, Ann Christin Rönnberg‐Wästljung, Thomas G. Egwang, et al.. (2007). Quantitative trait loci controlling cyanogenic glucoside and dry matter content in cassava (Manihot esculenta Crantz) roots. Hereditas. 144(4). 129–136. 42 indexed citations
17.
Kanoi, Bernard N. & Thomas G. Egwang. (2007). New concepts in vaccine development in malaria. Current Opinion in Infectious Diseases. 20(3). 311–316. 12 indexed citations
18.
Kizito, Elizabeth Balyejusa, Linley Chiwona‐Karltun, Thomas G. Egwang, Martín Fregene, & Anna Westerbergh. (2006). Genetic diversity and variety composition of cassava on small-scale farms in Uganda: an interdisciplinary study using genetic markers and farmer interviews. Genetica. 130(3). 301–318. 43 indexed citations
19.
Li, Jie, Sawako Itagaki, Brenda Okech, et al.. (2002). Serine Repeat Antigen (SERA5) Is Predominantly Expressed among the SERA Multigene Family of Plasmodium falciparum, and the Acquired Antibody Titers Correlate with Serum Inhibition of the Parasite Growth. Journal of Biological Chemistry. 277(49). 47533–47540. 81 indexed citations
20.
Egwang, Thomas G., Alain Dupont, A. Leclerc, Jean Paul Akué, & M Pinder. (1989). Differential Recognition of Loa loa Antigens by Sera of Human Subjects from a Loiasis Endemic Zone. American Journal of Tropical Medicine and Hygiene. 41(6). 664–673. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nutan Nanda Breakdown of academic impact, for papers by Luiz Hildebrando Pereira da Silva Breakdown of academic impact, for papers by Axel Martinelli Breakdown of academic impact, for papers by Ousmane Koita Breakdown of academic impact, for papers by Nafissatou Diagne Breakdown of academic impact, for papers by Kailash P. Patra Breakdown of academic impact, for papers by Cielo Pasay Breakdown of academic impact, for papers by Gustavo Fontecha Breakdown of academic impact, for papers by Albino Bobogare Breakdown of academic impact, for papers by Hema Joshi
Rankless by CCL
2026